March Madness Requires Both Shots To Defeat Meningococcal Disease
Mar 27, 2017
This guest post was provided by the National Meningitis Foundation (NMA) and first appeared on their Parents Who Protect blog.
As our obsession with basketball’s March Madness has progressed to the Final Four, our efforts to encourage “both shots” in the fight against meningococcal disease remain at center court.
While March is a time when basketball steals the headlines, it’s also a time when meningococcal disease steals our children. In fact, while meningococcal disease can strike at any time of year, the number of cases peaks in the winter and early spring. Unfortunately, for many National Meningitis Association (NMA) members, such as the member of Moms on Meningitis (M.O.M.) and Together Educating About Meningitis (T.E.A.M), March is a time when we remember those we lost to meningococcal disease.
- N.M.A. board member, Leslie Maier lost her son Chris on March 2nd
- M.O.M. Judy Miller lost her daughter Beth on March 12th
And there have been plenty of others who never got their “shot” at life.
The higher incidence of meningococcal disease in March can be seen in the headlines of the last few years.
In March 2014, a Drexel University student died after visiting Princeton University, which was nearing the end of an outbreak that impacted eight students. In 2015, the University of Oregon was battling an outbreak of meningococcal disease with two additional cases appearing in March. In 2016, students at both Penn State and Rutgers University were hospitalized with meningococcal disease in March. This year there were cases on three college campuses by mid-March: Wake Forest University, Old Dominion University, and Oregon State University. There has also been an outbreak, at an elementary school in Virginia.
To rise to the challenge of this other recurring “March Madness”, we must increase our efforts to raise awareness of meningococcal disease and its prevention.
There are two kinds of vaccines that students need to be protected from meningococcal disease, the MenACWY vaccine and the MenB vaccine.
- The Centers for Disease Control and Prevention (CDC) recommends meningococcal vaccination against serogroups A, C, W and Y for all children at 11-12 with a booster at age 16 (MenACWY).
- CDC recommends permissive use of meningococcal vaccination against serogroup B at ages 16-23, with a preferred age of 16 to 18 years (MenB). (Click here for more information.)
It’s important that students remain vigilant and be able to recognize the symptoms of meningococcal disease including headache, fever, stiff neck, and a purplish rash, so that you can promptly seek medical attention.
This March, let’s get on the ball and take “both shots” to prevent the other March Madness.
The National Meningitis Association is a nonprofit organization founded by parents whose children have died or live with permanent disabilities from meningococcal disease. Their mission is to educate people about meningococcal disease and its prevention. To stay informed about meningococcal disease and how to prevent it, follow The National Meningitis Association on Facebook and Twitter and be sure to subscribe to their Parents Who Protect blog.
Good news for parents – COVID vaccines are now available for children ages 6 months to 5 years old! We’re here to answer all of your questions about the COVID vaccines for babies and...
Are you boosted against COVID-19? Do you know if you’re eligible for your second booster? We’ve pulled together the information you need to understand the latest booster recommendations as of May 2022. As we...